Emerging Biomarker Technologies

Emerging biomarker technologies are revolutionizing cancer diagnostics and treatment by offering more sensitive and specific tools for detecting tumors at an early stage. Biomarkers—such as proteins, genetic mutations, or molecules—serve as indicators of disease presence and progression. With advances in high-throughput screening and next-generation sequencing, scientists are discovering novel biomarkers that can predict cancer susceptibility, diagnose cancer earlier, and monitor treatment response. Liquid biopsy, a non-invasive test that detects tumor DNA or RNA in blood samples, is one such promising technology. These biomarkers enable clinicians to personalize treatments more effectively and offer a less invasive alternative to traditional biopsy procedures, ultimately improving patient outcomes and reducing treatment costs.